Company intelligence / Profile preview

Dhiti Omics

Bengaluru, Karnataka, India

Ownership: Private
Development stage: Other

Overview

Dhiti Omics is an India-based precision molecular diagnostics company providing comprehensive genetic and genomic testing services for diagnostics, risk assessment, and personalized therapy guidance, with a focus on cancer, rare disorders, and reproductive health. The company utilizes advanced genomics technologies, AI-driven analytics (SOPHiA DDM), and multidisciplinary clinical expertise to deliver actionable reports for clinicians and researchers.

Therapeutic areas: Women's HealthOncologyRare Diseases
Modalities: Molecular diagnosticsGenomicsNext-generation sequencingGenetic testingBioinformatics
Industry: Molecular Diagnostics

Partnerships

SOPHiA Genetics (SOPHiA DDM Platform)Agilent (SureSelect Cancer CGP)

Beyond the preview

Go deeper on Dhiti Omics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dhiti Omics.

Explore the full profile